Tenax Therapeutics (TENX) Return on Capital Employed (2016 - 2017)

Tenax Therapeutics' Return on Capital Employed history spans 4 years, with the latest figure at 5.24% for Q3 2017.

  • For Q3 2017, Return on Capital Employed fell 457.0% year-over-year to 5.24%; the TTM value through Sep 2017 reached 5.24%, down 457.0%, while the annual FY2012 figure was 20.28%, N/A changed from the prior year.
  • Return on Capital Employed for Q3 2017 was 5.24% at Tenax Therapeutics, down from 4.64% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.67% in Q3 2016 and bottomed at 5.24% in Q3 2017.